mercredi 2 septembre 2015

Onco Actu du 2 septembre 2015

4. Dépistage, diagnostic et pronostic

Preventing Overdiagnosis 2015—winding back the harms of too much medicine [BMJ Blogs]

5. Traitements

Wasp study finds sting in the tail for cancer cells [The Guardian]

5.12 Immunothérapies

Advances in Immunotherapy: Fine-tuning CAR T Cells [CANCER RESEARCH Catalyst]

5.2 Pharma

Ragan Reunites Ex-Genzymers at X4 Pharma to Battle Cancer [Xconomy]

Industry complains to EU over French law pushing cheap eye drug [Reuters]

5.3 Traitements - FDA, EMA,...

Bristol-Myers and AbbVie speed toward FDA approval with a 'breakthrough' cancer drug [FierceBiotech]

EMA's medical literature monitoring enters into full operation [EMA]

6. Lutte contre les cancers

Giant study poses DNA data-sharing dilemma [Nature News & Comment]

We have breast cancer units – so why not prostate cancer units? [ESO-The Cancer Blog]

6.1 Observation

Two in Three Childhood Cancer Survivors Suffer Long-Term Side Effects [ACS]

6.10 Politiques

To Test Cancer Sooner, we need the Government to invest in the NHS [Cancer Research UK]

6.6 Publications

Altmetrics and Research Assessment: How Not to Let History Repeat Itself [The Scholarly Kitchen]

6.7 DMP, Big Data & applis

NIH grants seek best ways to combine genomic information and EHRs [NIH]

6.7.2 Applis

eHealth Application to Improve Care for Cancer Patients [ESMO]